Showing 181 - 200 results of 497 for search '"Фармакоэкономика"', query time: 0.04s Refine Results
  1. 181
    Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease

    Modeling the effect of enzyme replacement therapy on life-threatening complications in patients with Fabry disease by V. I. Ignatyeva, S. V. Moiseev, N. M. Bulanov, E. A. Karovajkina, A S. Moiseev

    Published 2019-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 182
    Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach

    Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach by A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya

    Published 2019-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 183
    Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation

    Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation by O. A. Gromova, I. Yu. Torshin, A. N. Gromov

    Published 2023-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 184
    PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION

    PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION by R. Yagudina, A. Kulikov, B. Misikova

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 185
    Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction

    Medical rehabilitation of patients with menopausal syndrome and surgical menopause: contribution of magnesium deficiency correction by D. V. Blinov, А. G. Solopova, Е. Е. Achkasov, G. К. Bykovshchenko, D. А. Petrenko

    Published 2023-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 186
    Review of open libraries for pharmacoeconomic analysis in R environment

    Review of open libraries for pharmacoeconomic analysis in R environment by I. A. Lackman, R. I. Sladkov, V. M. Timiryanova

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 187
    THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID

    THE ANALYSIS OF THE LIPETSK PHARMACEUTICAL MARKET OF NASAL GLUCOCORTICOSTEROID by K. V. Danilova, I. M. Razdorskaya

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 188
    A systematic review of real-world clinical practice data in COVID-19: non-interventional studies

    A systematic review of real-world clinical practice data in COVID-19: non-interventional studies by S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov

    Published 2022-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 189
    Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation

    Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation by D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy

    Published 2023-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 190
    Use of medications in children hospitalized with community-acquired pneumonia

    Use of medications in children hospitalized with community-acquired pneumonia by D. D. Siukaeva, I. A. Narkevich, V. N. Timchenko, O. D. Nemyatyh, N. A. Maslova

    Published 2018-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 191
    PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION

    PHARMACOECONOMIC ANALYSIS OF NEUROPROTECTIVE DRUGS IN THE TREATMENT OF ACUTE DISORDERS OF CEREBRAL CIRCULATION by A. Yu. Kulikov, I. Yu. Zinchuk

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 192
    Experience of using Beers criteria in clinical practice (according to Russian literature)

    Experience of using Beers criteria in clinical practice (according to Russian literature) by M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 193
    Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences

    Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences by E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 194
    Comparative chemomicrobiomic analysis of bacteriocins

    Comparative chemomicrobiomic analysis of bacteriocins by I. Yu. Torshin, O. A. Gromova

    Published 2024-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 195
    CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER

    CLINICAL AND ECONOMIC ANALYSIS OF THE USE OF DIFFERENT TYPES OF SYSTEMS OF VENOUS ACCESS IN THE TREATMENT OF CHILDREN WITH CANCER by Maksim Yur'evich Rykov, Vladimir Georgievich Polyakov

    Published 2015-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 196
    Biologically active supplements overview: regulation, market trends, application, and health impact

    Biologically active supplements overview: regulation, market trends, application, and health impact by A. M. Stepanova, A. N. Plutnitskiy, E. V. Gameeva

    Published 2024-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 197
    Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation

    Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation by A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev

    Published 2020-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 198
    CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation

    CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation by A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin

    Published 2018-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 199
    Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy

    Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy by N. А. Avxentyev, Yu. V. Makarova, V. V. Kadyshev

    Published 2022-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 200
    Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects

    Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects by A. N. Daikhes, D. V. Fedyaev

    Published 2017-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: